PHARM-OZ
Timeline
60 events since 1967Board
Capital
Filings
Financial
Establishments
197019751980198519901995200020052010201520202025
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 22 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0401670169
2025
Annual accounts 2024 filed PDFfull format · 7 days late
2024
Highest result from 2006 to 2025 net €105,313 ▲18% The operating result of €125,856 and the net result of €105,313 are both a record.
Company renamed from MAVEPHAR to PHARM-OZPermanent representative: ÖZ Mehmet · Appointment: PHARMA OZ (managing director) · PHARMA OZ holds all the shares · General meeting of 17-12-20249 points ▸
- General meeting, 17-12-2024
- Incorporation, 14-10-1967
- PHARMA OZ holds all the shares
- Incorporation, 03-01-2023
- Board composition, PHARMA OZ (director)
- Board composition, GEDERET Derya (director)
- Permanent representative, ÖZ Mehmet
- Name change, PHARM-OZ
- Director appointment, PHARMA OZ (managing director)
- The deed holds 6 more points.
Annual accounts 2023 filed PDFfull format · 48 days before the deadline
2023
2 directors appointed, 2 resignationsResignations: Véronique Vos (managing director) and Marc Van Aerschot (managing director) · Appointments: Pharma OZ SRL and Gederet Derya · Permanent representative: Mehmet Öz · General meeting of 31-03-20236 points ▸
- General meeting, 31-03-2023
- Director resignation, Véronique Vos (managing director)
- Director resignation, Marc Van Aerschot (managing director)
- Director appointment, Pharma OZ SRL
- Permanent representative, Mehmet Öz
- Director appointment, Gederet Derya
Annual accounts 2022 filed PDFfull format · 129 days before the deadline
2022
Annual accounts 2021 filed PDFfull format · 24 days before the deadline
2021
Annual accounts 2020 filed PDFfull format · 30 days before the deadline
2020
Demerger: MAVEPHAR splits off to MVA PharmaCapital increase of €6,901.46 to €61,500 · Capital from €54,598.54 to €61,500 · Reappointments: Marc Van Aerschot (director) and Véronique Vos (director) · General meeting of 17-06-202017 points ▸
- General meeting, 17-06-2020
- Marc Van Aerschot holds 125 shares, mentioned 3 times in the deed
- Véronique Vos holds 125 shares, mentioned 3 times in the deed
- 250 shares
- Incorporation, 14-10-1967
- Director reappointment, Marc Van Aerschot
- Director reappointment, Véronique Vos
- Auditor report, 29-05-2020
- Accounting effect, 01-01-2020
- Power of attorney, Marc Van Aerschot (managing director)
- Power of attorney, Véronique Vos (managing director)
- Capital increase, €6,901.46
- Capital, €61,500, 250 shares
- Registered office clause, Chaussée de Châtelet, 40 à 6060 Charleroi (ex-Gilly)
- Director appointment, Marc Van Aerschot (chair)
- Director appointment, Marc Van Aerschot (managing director)
- Director appointment, Véronique Vos (managing director)
- The deed holds 16 more points.
Demerger proposal: MAVEPHAR splits off to Sart AlletBoard meeting of 13-03-20202 points ▸
- Accounting effect, 01-01-2020
- Board meeting, 13-03-2020
- The deed holds 22 more points.
Annual accounts 2019 filed PDFfull format · 142 days before the deadline
2019
Annual accounts 2018 filed PDFfull format · 33 days before the deadline
2018
Annual accounts 2017 filed PDFfull format · 28 days before the deadline
2017
Annual accounts 2016 filed PDFfull format · 31 days before the deadline
2016
Annual accounts 2015 filed PDFfull format · 25 days before the deadline
2015
Annual accounts 2014 filed PDFfull format · 32 days before the deadline
2014
Annual accounts 2013 filed PDFfull format · 23 days before the deadline
2013
Equity above €200,000 equity €205,369 ▲18.1% After 3 profitable years in a row, equity reaches €205,369.
Annual accounts 2012 filed PDFfull format · 31 days late
2012
Equity above €150,000 equity €173,963 ▲18.5% After 2 profitable years in a row, equity reaches €173,963.
Annual accounts 2011 filed PDFfull format · 30 days late
2011
Back to profit net €101,922 The net result is €101,922, after 2 loss-making years.
Annual accounts 2010 filed PDFfull format · 31 days late
2010
Weakest financial year net -€80,702 The net result drops to -€80,702, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2009 filed PDFfull format · 31 days late
2009
Annual accounts 2008 filed PDFfull format · 31 days late
2008
Annual accounts 2007 filed PDFfull format · 4 days late
2007
Annual accounts 2006 filed PDFfull format · 30 days late
2006
Annual accounts 2005 filed PDFfull format
2005
Annual accounts 2004 filed PDFfull format
2004
Annual accounts 2003 filed PDFfull format
2003
Annual accounts 2002 filed PDFfull format
1998
Annual accounts 1997 filed PDFfull format
1997
Annual accounts 1996 filed PDFfull format
1996
Annual accounts 1995 filed PDFfull format
1995
Annual accounts 1994 filed PDFfull format
1994
Annual accounts 1993 filed PDFfull format
1992
Annual accounts 1990 filed PDFfull format
1988
Annual accounts 1987 filed PDFfull format
1985
Annual accounts 1984 filed PDFunclassified schema
1984
Annual accounts 1983 filed PDFunclassified schema
1983
Annual accounts 1982 filed PDFunclassified schema
1982
Annual accounts 1981 filed PDFunclassified schema
1981
Annual accounts 1980 filed PDFunclassified schema
1980
Annual accounts 1979 filed PDFunclassified schema
1979
Annual accounts 1978 filed PDFunclassified schema
1968
Incorporation KBO
1967
First establishment Chaussée de Châtelet 40, Charleroi
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank